TNF and rheumatoid arthritis: A 12-year persistence and male gender are both predictors of failure of the initial biologic therapy in patients with rheumatoid arthritis and psoriatic arthritis [87], while a lower efficacy of anti-TNF drugs is observed in females with axial spondyloarthritis [88].